AU3636797A - Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of (helicobacter pylori) infections - Google Patents

Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of (helicobacter pylori) infections

Info

Publication number
AU3636797A
AU3636797A AU36367/97A AU3636797A AU3636797A AU 3636797 A AU3636797 A AU 3636797A AU 36367/97 A AU36367/97 A AU 36367/97A AU 3636797 A AU3636797 A AU 3636797A AU 3636797 A AU3636797 A AU 3636797A
Authority
AU
Australia
Prior art keywords
infections
arginine
drugs
treatment
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36367/97A
Inventor
Lars Fandriks
Anders Pettersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOLDINGBOLAGET VID GOTEBORGS UNIVERSITET AB
Original Assignee
HOLDINGBOLAGET VID GOTEBORGS U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOLDINGBOLAGET VID GOTEBORGS U filed Critical HOLDINGBOLAGET VID GOTEBORGS U
Publication of AU3636797A publication Critical patent/AU3636797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU36367/97A 1996-02-27 1997-06-19 Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of (helicobacter pylori) infections Abandoned AU3636797A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600791A SE9600791L (en) 1996-02-27 1996-02-27 Method for eradication of Helicobacter pylori infection
PCT/SE1997/001101 WO1998057626A1 (en) 1996-02-27 1997-06-19 Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections

Publications (1)

Publication Number Publication Date
AU3636797A true AU3636797A (en) 1999-01-04

Family

ID=26662529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36367/97A Abandoned AU3636797A (en) 1996-02-27 1997-06-19 Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of (helicobacter pylori) infections

Country Status (3)

Country Link
AU (1) AU3636797A (en)
SE (1) SE9600791L (en)
WO (1) WO1998057626A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
AU772188B2 (en) 1998-11-17 2004-04-08 Nitromed, Inc. Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07267855A (en) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk Glutamine producing agent
EP0689835A3 (en) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition comprising a mixture of amino acids and at least one N-3 fatty acid

Also Published As

Publication number Publication date
WO1998057626A1 (en) 1998-12-23
SE9600791D0 (en) 1996-02-27
SE9600791L (en) 1997-08-28

Similar Documents

Publication Publication Date Title
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
PL314731A1 (en) S(+)-ibuprofen preparations for oral administration
AU7562296A (en) Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
AU6406299A (en) Methods and apparatus for improved administration of pharmaceutically active compounds
AU4048295A (en) Peptide medicaments for the treatment of disease
IL191582A (en) Process for preparing a pharmaceutical composition comprising ritonavir and use of form ii crystalline ritonavir for preparing a medicament
AU7931194A (en) Apparatus for treatment of the oral cavity
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
PT1165081E (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CINTENDO TOLPERISONA, FOR ORAL ADMINISTRATION
AU4560297A (en) Pharmaceutical microspheres of valproic acid for oral administration
AU9551298A (en) Use of coumarin derivatives for the treatment of digestive tract disorders
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
AU5811996A (en) Nanoparticles for oral administration of pharmaceutical agen ts of low solubility
AU1277792A (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
IL139817A0 (en) Non-hydrated gabapentin polymorph, a process for the preparation thereof and the use thereof for the preparation of pharmaceutical grade gabapentin
AU1354495A (en) Formulations for orally administered pharmaceutical agents
AU3636797A (en) Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of (helicobacter pylori) infections
AU3395093A (en) Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
AU2739497A (en) Use of vitamin d analogs for the treatment of arthritic disease
AU1190097A (en) Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
AU3407597A (en) Useful formulations of acid addition salt drugs
AU7291096A (en) Process for the preparation of anti-malarial drugs
AU7502194A (en) Medication administration apparatus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase